Hyperhomocysteinemia, lipid and lipoprotein disturbances in patients with primary hypertension

Aleksandra Baszczuk1, Katarzyna Musialik2, Jarosław Kopczyński2

  • 1Department of Laboratory Diagnostics, Poznan University of Medical Sciences, Poznan, Poland.

Insights

Patients with primary hypertension and hyperhomocysteinemia exhibit lower HDL-cholesterol and apo A-I levels. Elevated homocysteine correlates negatively with these lipid and lipoprotein parameters, suggesting increased atherosclerosis risk.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Biochemistry
  • Lipid Metabolism

Background:

  • Primary hypertension is a significant risk factor for cardiovascular disease.
  • Hyperhomocysteinemia, elevated homocysteine levels, is also linked to increased cardiovascular risk.
  • The interplay between hypertension, hyperhomocysteinemia, and lipid profiles requires further elucidation.

Purpose of the Study:

  • To determine serum concentrations of lipids and lipoproteins in patients with primary hypertension and hyperhomocysteinemia.
  • To investigate correlations between homocysteine levels and lipid/lipoprotein parameters in hypertensive patients.

Main Methods:

  • Study included 42 patients with primary hypertension and hyperhomocysteinemia, and 20 healthy controls.
  • Homocysteine measured by Fluorescence Polarization Immunoassay (FPIA).
  • Lipids (total cholesterol, LDL-C, HDL-C, triglycerides) measured enzymatically.
  • Apolipoproteins (apo A-I, apo B) and lipoprotein(a) measured nephelometrically.

Main Results:

  • Patients with primary hypertension and hyperhomocysteinemia showed significantly lower HDL-cholesterol and apo A-I concentrations compared to hypertensive individuals with normal homocysteine.
  • A negative correlation was observed between homocysteine levels and HDL-cholesterol.
  • A negative correlation was also found between homocysteine and apo A-I.

Conclusions:

  • The findings suggest that individuals with primary hypertension and hyperhomocysteinemia may have a higher susceptibility to atherosclerosis.
  • Lower HDL-cholesterol and apo A-I in this population underscore the combined atherogenic risk.
  • Further research is warranted to explore therapeutic strategies targeting homocysteine and lipid profiles in hypertensive patients.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
886
Alterations in Blood Pressure01:30

Alterations in Blood Pressure

Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
2.1K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
854
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K